Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,038 | 46,540 | 32,558 | 33,623 | 56,260 |
| Marketable Securities | 59,267 | 54,040 | 86,844 | 103,485 | 105,089 |
| Receivables | 2,009 | 2,822 | 532 | 3,371 | 1,505 |
| Inventories | 10,597 | 9,592 | 10,202 | 10,271 | 11,821 |
| TOTAL | $126,481 | $115,000 | $132,338 | $152,643 | $176,806 |
| Non-Current Assets | |||||
| PPE Net | 12,779 | 14,329 | 15,514 | 16,937 | 17,592 |
| Other Non-Current Assets | 514 | 354 | 356 | 350 | 340 |
| TOTAL | $13,293 | $14,683 | $15,870 | $17,287 | $17,932 |
| Total Assets | $139,774 | $129,683 | $148,208 | $169,930 | $194,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,011 | 2,988 | 2,897 | 4,061 | 4,250 |
| Accrued Expenses | 7,425 | 8,204 | 7,009 | 6,539 | 11,478 |
| Other current liabilities | 182 | 173 | 165 | 156 | 148 |
| TOTAL | $13,579 | $14,743 | $13,626 | $14,926 | $19,796 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,746 | N/A | 2,386 | 2,617 | 2,849 |
| Deferred Revenues | 2,961 | 3,378 | 3,555 | 4,170 | 3,920 |
| Other Non-Current Liabilities | 3,564 | 4,758 | 2,659 | 2,705 | 2,747 |
| TOTAL | $19,104 | $5,558 | $6,045 | $6,800 | $7,039 |
| Total Liabilities | $32,683 | $20,301 | $19,671 | $21,726 | $26,835 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,824 | 57,497 | 56,165 | 55,760 | 55,582 |
| Common Shares | 664,204 | 56 | 642,822 | 639,751 | 636,903 |
| Retained earnings | -557,124 | -536,020 | -514,351 | -491,622 | -469,135 |
| Other shareholders' equity | 11 | 30 | 66 | 75 | 135 |
| TOTAL | $107,091 | $109,382 | $128,537 | $148,204 | $167,903 |
| Total Liabilities And Equity | $139,774 | $129,683 | $148,208 | $169,930 | $194,738 |